(Q49113577)

18 February 2018

title

Full remission and relapse of obsessive-compulsive symptoms after cognitive-behavioral group therapy: a two-year follow-up. (English)

1 reference

18 February 2018

1 reference

Daniela Tusi Braga

1

1 reference

18 February 2018

Gisele Gus Manfro

series ordinal

2

1 reference

18 February 2018

Kátia Niederauer

series ordinal

3

1 reference

18 February 2018

Aristides Volpato Cordioli

series ordinal

4

1 reference

18 February 2018

publication date

1 June 2010

1 reference

18 February 2018

Brazilian Journal of Psychiatry

published in

1 reference

18 February 2018

volume

32

1 reference

18 February 2018

page(s)

164-168

1 reference

18 February 2018

issue

2

1 reference

18 February 2018

Cognitive-behavioral group therapy in obsessive-compulsive disorder: a randomized clinical trial.

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462010000200012

The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462010000200012

Long-term course and outcome of obsessive-compulsive patients after cognitive-behavioral therapy in combination with either fluvoxamine or placebo: a 7-year follow-up of a randomized double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462010000200012

A randomized clinical trial of cognitive-behavioral group therapy and sertraline in the treatment of obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462010000200012

Addition of cognitive-behaviour therapy for obsessive-compulsive disorder patients non-responding to fluoxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462010000200012

Randomized, Placebo-Controlled Trial of Exposure and Ritual Prevention, Clomipramine, and Their Combination in the Treatment of Obsessive-Compulsive Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462010000200012

10.1590/S1516-44462010000200012

21 January 2018

Identifiers

DOI

1 reference

18 February 2018

PubMed ID

20658055

1 reference

18 February 2018